BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GDEN
3101
DELISTED
Golden Entertainment
GDEN
| $11.3M | ﹤0.01% |
1,262,278
-69,994
| -5% | -$651K |
|
3102
Westwood Holdings Group
WHG
$182M
| $11.3M | ﹤0.01% |
714,601
-10,298
| -1% | -$196K |
|
3103
Cartesian Therapeutics
RNAC
$260M
| $11.2M | ﹤0.01% |
131,923
+108,744
| +469% | +$9.86M |
|
|
BFIN
3104
DELISTED
BankFinancial
BFIN
| $11.2M | ﹤0.01% |
1,336,750
-76,270
| -5% | -$610K |
|
3105
Southern First Bancshares
SFST
$603M
| $11.2M | ﹤0.01% |
404,832
-6,340
| -2% | -$172K |
|
3106
CorMedix
CRMD
$573M
| $11.2M | ﹤0.01% |
1,778,890
+67,219
| +4% | +$311K |
|
|
CBIO
3107
Crescent Biopharma
CBIO
$620M
| $11.2M | ﹤0.01% |
29,733
+2,009
| +7% | +$569K |
|
|
KALV
3108
DELISTED
KalVista Pharmaceuticals
KALV
| $11.2M | ﹤0.01% |
923,851
+51,394
| +6% | +$547K |
|
|
VWTR
3109
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $11.2M | ﹤0.01% |
1,323,506
-3,814
| -0.3% | -$30.5K |
|
|
KIN
3110
DELISTED
Kindred Biosciences, Inc.
KIN
| $11.1M | ﹤0.01% |
2,481,652
+19,390
| +0.8% | +$86.7K |
|
|
LUNA
3111
DELISTED
Luna Innovations Incorporated
LUNA
| $11.1M | ﹤0.01% |
1,903,181
+1,421,849
| +295% | +$9.26M |
|
3112
iShares Global REIT ETF
REET
$5.01B
| $11.1M | ﹤0.01% |
532,151
-219,293
| -29% | -$4.43M |
|
|
BRT
3113
BRT Apartments
BRT
$265M
| $11.1M | ﹤0.01% |
1,026,670
+30,835
| +3% | +$314K |
|
3114
Home Bancorp
HBCP
$564M
| $11.1M | ﹤0.01% |
414,867
-9,447
| -2% | -$231K |
|
|
PVLA
3115
Palvella Therapeutics
PVLA
$2.22B
| $11.1M | ﹤0.01% |
44,626
+2,657
| +6% | +$621K |
|
3116
Telefônica Brasil
VIV
$18.6B
| $11.1M | ﹤0.01% |
1,249,052
+22,072
| +2% | +$200K |
|
3117
Plains GP Holdings
PAGP
$4.97B
| $11.1M | ﹤0.01% |
1,242,461
+146,753
| +13% | +$1.29M |
|
|
NID
3118
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
| $11M | ﹤0.01% |
+831,517
| New | +$10.6M |
|
3119
Red River Bancshares
RRBI
$674M
| $11M | ﹤0.01% |
249,832
-4,706
| -2% | -$184K |
|
3120
BeyondSpring
BYSI
$32.5M
| $11M | ﹤0.01% |
726,745
+37,468
| +5% | +$572K |
|
|
LTRPA
3121
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $11M | ﹤0.01% |
5,143,883
-332,202
| -6% | -$757K |
|
|
STMP
3122
PUT
DELISTED
Stamps.com, Inc.
STMP
| $10.9M | ﹤0.01% |
+59,500
| New | +$10.2M |
|
|
GAN
3123
DELISTED
GAN Ltd
GAN
| $10.9M | ﹤0.01% |
+428,436
| New | +$8.2M |
|
3124
Rocky Brands
RCKY
$355M
| $10.9M | ﹤0.01% |
529,945
-15,901
| -3% | -$317K |
|
3125
Woori Financial
WF
$17.1B
| $10.8M | ﹤0.01% |
+489,122
| New | +$10.3M |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.